Health

Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 19, 2025 16:15 ET  | Source: Zenas BioPharma WALTHAM, Mass., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc.…

3 weeks ago

Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes

ZHUHAI, China, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Rezubio, a China-based biotechnology company founded by former Merck scientists, today announced…

3 weeks ago

Is SkinnyRx the Best GLP-1 Vendor for 2026? Platform Offers Compounded Semaglutide in Three Forms Starting at $199/Month as New Year Weight Loss Season Approaches

Sacramento, Dec. 18, 2025 (GLOBE NEWSWIRE) -- With the New Year fast approaching and consumer interest in weight loss solutions…

3 weeks ago

Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

December 18, 2025 19:00 ET  | Source: Mesa Laboratories, Inc. LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories,…

3 weeks ago

Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR

Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted DSR patents in US, Europe, Japan and ChinaStrengthens…

3 weeks ago

InnoCare Announces Approval of Phase II/III Clinical Trial of Novel TYK2 Inhibitor Soficitinib for Chronic Spontaneous Urticaria in China

December 17, 2025 20:48 ET  | Source: InnoCare Pharma BEIJING, Dec. 17, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969;…

3 weeks ago

Sapu BioScience Highlights TGFB2-Guided Strategy to Enhance Taxane Therapies, Reinforcing the Rationale for Sapu-001

San Diego, CA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Sapu BioScience today announced the publication of a new peer-reviewed study…

3 weeks ago

Rakovina Therapeutics Management to Attend Partnering Meetings During JPM Week, January in San Francisco, California

VANCOUVER, British Columbia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina” or the “Company”),…

4 weeks ago

Festive drinking and hormones: Clue shares science-backed guidance for Christmas

LONDON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- With office parties, cocktails with friends and end-of-year celebrations in full swing, many…

4 weeks ago

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic

COPENHAGEN, Denmark, December 17, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that, following the recent appointment of Anne…

4 weeks ago